Galodé Francois, Ladipo O, Andrieux A, Feghali H, Bui S, Fayon Michael
Paediatric Cystic Fibrosis Reference Center, Hôpital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux, France.
Service de Pédiatrie, CHU de la Mère et de l'Enfant Lagune, Cotonou, Benin.
Front Pediatr. 2022 May 12;10:856840. doi: 10.3389/fped.2022.856840. eCollection 2022.
Many patients with cystic fibrosis (CF) wheeze, and are dubbed as having CF-asthma. Understanding the determinants of such wheezing may avoid unnecessary treatments and open newer treatment avenues.
Main: To evaluate the prevalence and characteristics of wheezing and a positive bronchodilatory response (BDR) in children with CF. Secondary: To identify the predictive markers and the impact of current wheezing a positive BDR.
A retrospective single-center study in children with CF. We determined the characteristics of physician-reported wheeze in patients <6 years, and a BDR in patients aged 6-17 years. Anthropometric, lung function, laboratory, genetic and microbiological data were recorded in all groups. Variables were compared using the Chi and Student -tests, and ANOVA.
125 preschool and 69 school-aged children and adolescents with CF were included in the study. 71.2% of patients <6 years of age had had at least one episode of wheezing: 26.3% of patients were Transient Early Wheezers, 12.6% Late Onset Wheezers and 37.9% were Persistent Wheezers. The prevalence of a positive BDR was 73.5, 48.5, and 52.9% in the 6-8 years, 10-12 years, and 15-17 years age groups, respectively. Allergic factors were not predictive of wheezing in preschoolers. In the 6-8 years age group, the sum of wheal diameters of allergic skin prick tests (SPT, house dust mite + cat + dog dander) was greater in those with a BDR vs. no BDR (4 [2.0-8.8] vs. 1 [0-7.0] mm, = 0.01). The presence of in the bronchial secretions before 3 years of age was not significantly associated with either the presence of wheezing at the age of 6 years or a BDR in school-aged children and adolescents. The proportion of homozygous p.F508del patients was significantly lower in the group of patients who had wheezed by 6 years of age (60% vs. 72.7%, = 0.009), but higher in the 6-8 years old group with a BDR vs. no BDR (64% vs. 36%, = 0.04). Current wheezers at 6 years had a lower mean FEV vs. the non-current wheezers (91.5 ± 4.4% vs. 100.9 ± 2.4%; = 0.047). Similarly, forced vital capacity (FVC) was significantly lower in the 6-8 years old group with BDR vs. no BDR (85 ± 19 vs. 101 ± 21%, = 0.015).
Wheezing and BDR are very frequent findings in children with CF. Current wheeze at the age of 6 years was associated with worse lung function. Labeling wheezing in CF as "CF-Asthma" is misleading since the determinants are different, and may lead to inappropriate prescriptions of inhaled steroids.
许多囊性纤维化(CF)患者会出现喘息,被称为患有CF-哮喘。了解此类喘息的决定因素可避免不必要的治疗,并开辟新的治疗途径。
主要目的:评估CF患儿喘息及阳性支气管舒张反应(BDR)的患病率和特征。次要目的:确定预测指标以及当前喘息及阳性BDR的影响。
对CF患儿进行一项回顾性单中心研究。我们确定了6岁以下患者医生报告的喘息特征,以及6至17岁患者的BDR。记录了所有组的人体测量、肺功能、实验室、基因和微生物学数据。使用卡方检验、学生t检验和方差分析对变量进行比较。
本研究纳入了125名学龄前儿童和69名学龄儿童及青少年CF患者。6岁以下患者中71.2%至少有过一次喘息发作:26.3%的患者为短暂早期喘息者,12.6%为迟发性喘息者,37.9%为持续性喘息者。6至8岁、10至12岁和15至17岁年龄组中阳性BDR的患病率分别为73.5%、48.5%和52.9%。过敏因素不能预测学龄前儿童的喘息。在6至8岁年龄组中,有BDR者与无BDR者相比,过敏性皮肤点刺试验(SPT,屋尘螨+猫+狗皮屑)的风团直径总和更大(4[2.0-8.8]mm对1[0-7.0]mm,P=0.01)。3岁前支气管分泌物中存在[此处原文缺失具体内容]与6岁时喘息的存在或学龄儿童及青少年的BDR均无显著相关性。6岁前喘息患者组中纯合子p.F508del患者的比例显著低于未喘息患者组(60%对72.7%,P=0.009),但在6至8岁有BDR组中高于无BDR组(64%对36%,P=0.04)。6岁时当前喘息者的平均第一秒用力呼气容积(FEV)低于非当前喘息者(91.5±4.4%对100.9±2.4%;P=0.047)。同样,6至8岁有BDR组的用力肺活量(FVC)显著低于无BDR组(85±19对101±21%,P=0.015)。
喘息和BDR在CF患儿中很常见。6岁时当前喘息与较差的肺功能相关。将CF中的喘息标记为“CF-哮喘”具有误导性,因为决定因素不同,可能导致吸入性类固醇的不适当处方。